HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Recommendation of “Buy” by Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been given a consensus recommendation of “Buy” by the twelve ratings firms that are covering the stock, Marketbeat Ratings reports. Twelve investment analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $103.83.

HQY has been the subject of several recent analyst reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a research note on Wednesday. Deutsche Bank Aktiengesellschaft raised their target price on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday. Barrington Research reiterated an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Friday, August 30th. Wells Fargo & Company raised their target price on shares of HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a research note on Thursday, June 20th. Finally, Bank of America cut their target price on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday.

Insider Activity at HealthEquity

In related news, CEO Jon Kessler sold 32,326 shares of the company’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the sale, the chief executive officer now directly owns 232,176 shares in the company, valued at approximately $19,231,138.08. The sale was disclosed in a filing with the SEC, which is available through this link. In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of the firm’s stock in a transaction that occurred on Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the sale, the chief executive officer now owns 232,176 shares in the company, valued at $19,231,138.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the transaction, the insider now owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The disclosure for this sale can be found here. Insiders have sold 75,031 shares of company stock valued at $6,103,625 over the last three months. 2.20% of the stock is owned by insiders.

Hedge Funds Weigh In On HealthEquity

Several large investors have recently bought and sold shares of the company. Cape Investment Advisory Inc. bought a new stake in shares of HealthEquity in the 4th quarter valued at about $27,000. Rise Advisors LLC bought a new stake in HealthEquity in the first quarter valued at approximately $28,000. International Assets Investment Management LLC acquired a new stake in HealthEquity during the 2nd quarter valued at approximately $35,000. YHB Investment Advisors Inc. bought a new position in HealthEquity during the 1st quarter worth approximately $40,000. Finally, Fidelis Capital Partners LLC bought a new position in HealthEquity during the 1st quarter worth approximately $42,000. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Trading Down 4.1 %

HealthEquity stock opened at $76.24 on Monday. The firm has a 50-day moving average of $77.03 and a 200-day moving average of $79.67. HealthEquity has a one year low of $61.81 and a one year high of $88.26. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.39 and a quick ratio of 4.39. The company has a market cap of $6.63 billion, a price-to-earnings ratio of 82.87, a P/E/G ratio of 1.34 and a beta of 0.52.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.